From AVAC <[email protected]>
Subject The Latest Updates and Resources: UNAIDS meeting, HVAD webinars, and more
Date June 14, 2023 8:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** A Recap of Resources: UNAIDS meeting, HVAD webinars and more
------------------------------------------------------------
June 14, 2023

Dear Advocate,

In this round up of updates and resources, you’ll find a read-out of the May UNAIDS high-level meeting in Geneva, two webinars that spotlight critical issues for vaccines R&D and the potential of broadly neutralizing antibodies, and an upcoming webinar looking at alternatives to long-acting PrEP. Read on and join us!

The HIV Response at UNAIDS High-level Meeting
A high-level meeting in Geneva, held by UNAIDS last month on the margins of the World Health Assembly, brought together advocates and experts through the Global HIV Prevention Coalition ([link removed]) to discuss where action is needed most to bolster HIV response and advance global health equity. Read AVAC’s summary of the meeting ([link removed]) in our latest P-Values blog.

[link removed]

Vaccines in 2023 and Beyond
AVAC hosted two webinars in commemoration of HIV Vaccine Awareness Day ([link removed]) . They offer a snapshot on the state of the field for an HIV vaccine, and explore considerations for the development and delivery of vaccines against future pandemics. Check them out below and read more in our HVAD one-pager ([link removed]) !


What’s All the Buzz About: mRNA, manufacturing, vaccine access ([link removed])
Local production has emerged as an essential part of the solution for ensuring sustainable and equitable supplies of vaccines in low- and middle-income countries. This webinar explored how local manufacturing and the new mRNA Hub in South Africa could facilitate access and support R&D. Check out the summary and recording ([link removed]) .

To bNAb or Not to bNAb? The case for broadly neutralizing antibodies ([link removed])
AVAC and partners explored the potential role of bNAbs in prevention, the status of research and development, and implications for HIV vaccine research. Check out the summary and recording ([link removed]) .

------------------------------------------------------------

Upcoming

[link removed] In Black America Presents Mpox Webinar
Pr ([link removed]) EP in Black America ([link removed]) alongside a panel of experts will discuss the impact of mpox on Black communities, advocacy and mobilization to keep our communities safe, and information on vaccine effectiveness. Tuesday, June 20 at 2:00 PM to 3:30 PM ET. Register here. ([link removed])


[link removed] That Booty: The latest on rectal microbicide research for the back door Most of the coverage of the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices. Learn more about the alternatives at this webinar. Thursday, June 29 at 9:00 AM to 10:30 AM ET. ([link removed]) Register ([link removed]) here ([link removed]) .
Best,
AVAC

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis